UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 144

Sortiert nach

Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials

Journal of neurology, neurosurgery and psychiatry, 2020-11, Vol.91 (11), p.1201

2020

Link zum Volltext

Verfügbarkeit prüfen

Meta-analysis of modifiable risk factors for Alzheimer's disease

Journal of neurology, neurosurgery and psychiatry, 2015-12, Vol.86 (12), p.1299-1306

2015

Link zum Volltext

Verfügbarkeit prüfen

The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis

Journal of affective disorders, 2016-01, Vol.190, p.264-271

2016

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: a systematic review and meta-analysis of cohort studies

Journal of neurology, neurosurgery and psychiatry, 2016-05, Vol.87 (5), p.476-484

2016

Link zum Volltext

Verfügbarkeit prüfen

Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre‐activation of AMPK‐dependent autophagy

British journal of pharmacology, 2014-07, Vol.171 (13), p.3146-3157

2014

Link zum Volltext

Verfügbarkeit prüfen

Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease

Trends in molecular medicine, 2013-10, Vol.19 (10), p.594-603

2013

Link zum Volltext

Verfügbarkeit prüfen

The NLRP3 Inflammasome in Alzheimer’s Disease

Molecular neurobiology, 2013-12, Vol.48 (3), p.875-882

2013

Link zum Volltext

Verfügbarkeit prüfen

Education and Risk of Dementia: Dose-Response Meta-Analysis of Prospective Cohort Studies

Molecular Neurobiology, 2016-07, Vol.53 (5), p.3113-3123

2016

Link zum Volltext

Verfügbarkeit prüfen

Dietary Patterns and Risk of Dementia: a Systematic Review and Meta-Analysis of Cohort Studies

Molecular neurobiology, 2016-11, Vol.53 (9), p.6144-6154

2016

Link zum Volltext

Verfügbarkeit prüfen

Resveratrol as a Therapeutic Agent for Alzheimer’s Disease

BioMed research international, 2014-01, Vol.2014, p.350516-13

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis

Journal of Alzheimer's disease, 2015-01, Vol.43 (2), p.589

2015

Link zum Volltext

Verfügbarkeit prüfen

Upregulation of TREM2 Ameliorates Neuropathology and Rescues Spatial Cognitive Impairment in a Transgenic Mouse Model of Alzheimer's Disease

Neuropsychopharmacology (New York, N.Y.), 2014-12, Vol.39 (13), p.2949-2962

2014

Link zum Volltext

Verfügbarkeit prüfen

Circulating miR-125b as a biomarker of Alzheimer's disease

Journal of the neurological sciences, 2014-01, Vol.336 (1), p.52-56

2014

Link zum Volltext

Verfügbarkeit prüfen

Amyloid Pathology Modulates the Associations of Neuropsychiatric Symptoms with Cognitive Impairments and Neurodegeneration in Non-Demented Elderly

Journal of Alzheimer's disease, 2024-01, Vol.97 (1), p.471

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials

Alzheimer's research & therapy, 2018-12, Vol.10 (1), p.126-126, Article 126

2018

Link zum Volltext

Verfügbarkeit prüfen

Associations of Alzheimer's disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration

Alzheimer's research & therapy, 2021-01, Vol.13 (1), p.15-15, Article 15

2021

Link zum Volltext

Verfügbarkeit prüfen

The Role of TDP-43 in Alzheimer’s Disease

Molecular Neurobiology, 2016-07, Vol.53 (5), p.3349-3359

2016

Link zum Volltext

Verfügbarkeit prüfen

Cognitive Reserve and Alzheimer’s Disease

Molecular neurobiology, 2015-02, Vol.51 (1), p.187-208

2015

Link zum Volltext

Verfügbarkeit prüfen

Microglia in Alzheimer’s Disease

BioMed research international, 2014-01, Vol.2014, p.437483-7

2014

Link zum Volltext

Verfügbarkeit prüfen

Targeting the mTOR Signaling Network for Alzheimer’s Disease Therapy

Molecular neurobiology, 2014-02, Vol.49 (1), p.120-135

2014

Link zum Volltext

Verfügbarkeit prüfen

Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice

Neurobiology of aging, 2015-12, Vol.36 (12), p.3176-3186

2015

Link zum Volltext

Verfügbarkeit prüfen

A rare coding variant in TREM2 increases risk for Alzheimer’s disease in Han Chinese

Neurobiology of aging, 2016-06, Vol.42, p.217.e1-217.e3

2016

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of caspase-1 ameliorates tauopathy and rescues cognitive impairment in SAMP8 mice

Metabolic brain disease, 2022-04, Vol.37 (4), p.1197-1205

2022

Link zum Volltext

Verfügbarkeit prüfen

Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort

BMC neurology, 2022-02, Vol.22 (1), p.59-59, Article 59

2022

Link zum Volltext

Verfügbarkeit prüfen

Midlife vascular risk factors and the risk of Alzheimer's disease: a systematic review and meta-analysis

Journal of Alzheimer's disease, 2014-01, Vol.42 (4), p.1295

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 144

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(117)

Publikationsform

Artikel
(144)

Sprache

Englisch
(144)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials

Meta-analysis of modifiable risk factors for Alzheimer's disease

The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis

Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: a systematic review and meta-analysis of cohort studies

Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre‐activation of AMPK‐dependent autophagy

Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease

The NLRP3 Inflammasome in Alzheimer’s Disease

Education and Risk of Dementia: Dose-Response Meta-Analysis of Prospective Cohort Studies

Dietary Patterns and Risk of Dementia: a Systematic Review and Meta-Analysis of Cohort Studies

Resveratrol as a Therapeutic Agent for Alzheimer’s Disease

Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis

Upregulation of TREM2 Ameliorates Neuropathology and Rescues Spatial Cognitive Impairment in a Transgenic Mouse Model of Alzheimer's Disease

Circulating miR-125b as a biomarker of Alzheimer's disease

Amyloid Pathology Modulates the Associations of Neuropsychiatric Symptoms with Cognitive Impairments and Neurodegeneration in Non-Demented Elderly

Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials

Associations of Alzheimer's disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration

The Role of TDP-43 in Alzheimer’s Disease

Cognitive Reserve and Alzheimer’s Disease

Microglia in Alzheimer’s Disease

Targeting the mTOR Signaling Network for Alzheimer’s Disease Therapy

Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice

A rare coding variant in TREM2 increases risk for Alzheimer’s disease in Han Chinese

Inhibition of caspase-1 ameliorates tauopathy and rescues cognitive impairment in SAMP8 mice

Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort

Midlife vascular risk factors and the risk of Alzheimer's disease: a systematic review and meta-analysis

Suchergebnisse filtern